JavaScript Required We're sorry, but this site doesn't work properly without JavaScript enabled. If you can't enable JavaScript please click here to view settings.

All India Institute of Medical Sciences, Nagpur

  • Name: Dr. Vandana Singh Kushwaha
  • Designation: Assistant Professor
  • Qualification: MBBS, MD Radiotherapy, FRCR Clinical Oncology (RCR London)
  • Department: Radiotherapy
  • Official Email id: radonco@aiimsnagpur.edu.in
  • Areas of Interest: High Precision radiotherapy, Lung cancer, Gastrointestinal tumor, Brain tumor, Molecular oncology, Tumor Immunology & Personalized Cancer Medicine

 

 

Membership of scientific societies and Trainin:

  • Association of Radiation Oncologists of India (AROI)
  • Indian Brachytherapy Society
  • American Society for Radiation Oncology (ASTRO) – web based
  • American Society for Clinical Oncology (ASCO) – web based
  • European Society for Medical Oncology (ESMO)
  • European Society for Radiotherapy & Oncology (ESTRO)
  • Royal College of Radiologist (RCR)
  • Georgian Alumni Association, Lucknow

Publications:

  • Chatakonda SS, Vishwanathan B, Narayanan GS, Kapurmath SV, Kushwaha VS*, Narayanan SS, Venugopal R. Comparison of Hyperfractionated Radiotherapy with Concomitant Chemotherapy and Conventional Chemoradiotherapy in Locally Advanced Head and Neck Cancer Treated with Volumetric Modulated Arc Technique (VMAT). Acta Scientific Cancer Biology. 5.5 (2021): 02-11.
  • Kumar S, Kaundal V, Sood S, Kushwaha VS, Verma S, Negi M, Gupta N. Challenges and Management in Gynaecological Cancers in Covid 19 Crises: An Institutional Experience. Acta Scientific Cancer Biology .12 (2020): 03-09.
  • Abbas M, Kushwaha VS, Srivastava K, Raza ST, Banerjee M. Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer. British Journal of Biomedical Science. 2018 Oct;75(4):169-174. PMID: 29909733
  • Gupta S, Kushwaha VS, Verma S, Khan H, Bhatt ML, Husain N, Negi MPS, Bhosale VV, Ghatak A. Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation. Heliyon 2 (2016) e00206. doi: 10.1016/j.heliyon. 2016.e00206. PMCID: PMC5148783
  • Abbas M, Kushwaha VS, Srivastava K, Banerjee M. “Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation”. PLoS One. 2015 Nov 16;10(11):e0142501. doi: 10.1371/journal.pone.0142501. PMID: 26571237

Recognition in "World Biomedical Frontiers Magazine"

  • Study on “Gefitinib and Methotrexate plus 5-Florouracil in recurrent head and neck squamous cell carcinoma” was invited for featuring on World Biomedical Frontiers Magazine because of its innovation and potential for significant impact, http://biomedfrontiers.org/ ISSN: 2328-0166.

Book/Chapter published:

         “Expression of p53, Cyclin-D1 & EGFR in oral squamous cell carcinoma”- Molecular Marker Expression in Oral Cancer.

          Editors: Seema Gupta, Huma Khan and Vandana Singh Kushwaha

          Typeset and printed by Lambert Academic Publishing, Schaltungsdienst Lange o.H.G., Berlin, First edition,2015. ISBN:978-3-659-67291-0

Miscellaneous:

Presentations: Presented 8 papers in National & International conferences

Honours and Awards:

  • Awarded the AROI fellowship for age group <35 years for year 2015-2016
  • Awarded second prize for poster presentation in CLINRESCON-2014 organized by Central Drug Research Institute (CDRI/ICMR)
  • Awarded “Best Performance” in MD, Radiotherapy Examination 2013.

Skills:

  • Image Guided Radiotherapy (IGRT), Volumetric Arc Radiotherapy (VMAT), Stereotactic Radiosurgery (SRS) & Stereotactic Body Radiotherapy (SBRT)
  • Worked on Cyberknife and Tomotherapy
  • Brachytherapy including Image based radiotherapy (IGBT) & Interstitial brachytherapy Cervix
  • Chemotherapy